Invicta Diagnostic SME IPO GMP Today

GMP for Invicta Diagnostic SME started at Rs 0 on 25 November 2025 and stood at Rs 0 on 4 December 2025. The sharpest single-day jump was from Rs 0 on 1 Dec 2025 to Rs 3 on 2 Dec 2025. GMP has moved in both directions during the tracked period. That often means sentiment is unsettled and the final listing price is harder to predict.

Based on today's GMP, Invicta Diagnostic SME IPO listing price estimate is Rs 85.00 per share (issue price Rs 85.00 + GMP Rs 0.00).

Actual listing price will be known on 8 December 2025 when the stock lists on NSE/BSE.

Grey market activity is minimal or unavailable. GMP may appear once investor interest builds closer to the open date.

GMP is unofficial. Listing gain can differ on listing day.

GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Invicta Diagnostic SME is 4.27x. Compare this with the GMP trend to see if demand aligns. The GMP move around 2 Dec 2025 may reflect how the market reacted once the subscription window activity picked up after 1 Dec 2025.

See live figures on the Invicta Diagnostic SME IPO Subscription Status page.

Invicta Diagnostic SME IPO full details (financials, peers, review).

Invicta Diagnostics (PC Diagnostics) is a diagnostic chain operating primarily in the Mumbai Metropolitan Region (MMR). The company provides a one-stop solution by offering both radiology (X-ray, CT, MRI, PET CT) and pathology (routine and specialized tests) services through a hub-and-spoke model. The network includes 7 diagnostic centres and 1 centralised laboratory across MMR, ensuring high-end services are accessible. The company focuses on improving customer convenience through home sample collection and multiple report delivery options.